Results 131 to 140 of about 16,057 (260)

Correction: Editorial: Schools as an arena for health-promoting physical activity. [PDF]

open access: yesFront Sports Act Living
Barene S   +3 more
europepmc   +1 more source

Extraocular Photoreception in Optic Lobes, Suckers, and Skin of Octopus vulgaris

open access: yesIntegrative Zoology, EarlyView.
Evidence of extra‐ocular photoreception in Octopus vulgaris (a) Diagram of the O. vulgaris different tissues considered: SPB, sucker proximal big; SPL, sucker proximal large; SM, sucker medium; SD, sucker distal; SK, skin; OL, optic lobes; RT, retina; (b‐d) Gene expression analysis of Ov‐GRK1 (red), Ov‐retinochrome (green), Ov‐rhodopsin (blue) mRNA ...
Valeria Maselli   +7 more
wiley   +1 more source

Local Field Potential‐Based Programming: A Proof‐of‐Concept Pilot Study

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives Programming deep brain stimulation (DBS) is still based on a trial‐and‐error approach, often becoming a time‐consuming process for both treating physicians and patients. Several strategies have been proposed to streamline DBS programming, most of which are preliminary and mainly address Parkinson's disease, a condition readily ...
Alfonso Fasano   +10 more
wiley   +1 more source

Plasma CA125 as a Prognostic Marker in Very Elderly Patients Hospitalized for Acute Heart Failure. [PDF]

open access: yesJ Clin Med
Jaramillo-Hidalgo J   +5 more
europepmc   +1 more source

Serotonin Degradation and Lipid Metabolism Regulate Human Tc2 Cell Effector Functions

open access: yesAllergy, EarlyView.
Human Tc2 cells exhibit a metabolically active phenotype characterized by enhanced glycolysis, mitochondrial respiration, and fatty acid uptake dependent on PPARγ. Alarmins strongly amplify IL‐5 and IL‐13 production in Tc2 cells, supporting a shared immunometabolic program across type 2 lymphocytes.
Sabrina de Souza Ferreira   +13 more
wiley   +1 more source

Remission in Global Airway Diseases: EUFOREA Consensus Paper

open access: yesAllergy, EarlyView.
ABSTRACT The therapeutic goal in chronic airway diseases is shifting from symptom control to disease remission. Disease‐modifying therapies, including biologics and allergen immunotherapy, have made remission achievable in patients with severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), or allergic rhinitis (AR).
J. Christian Virchow   +22 more
wiley   +1 more source

Perforated Jejunal Pseudodiverticulum Managed With Limited Segmental Resection: A Case Report. [PDF]

open access: yesCureus
Lozano-Carrillo LC   +4 more
europepmc   +1 more source

Disciplining the “Queen of the World”? Responsible Innovation as a Way of Life

open access: yesBusiness Ethics, the Environment &Responsibility, EarlyView.
ABSTRACT This paper offers a critical reflection on the concept of responsible innovation as defined during the last decades. We argue that the emphasis on innovation as a process risks neglecting the very goals of innovation, namely societal desirability and acceptability. Thus, we suggest reconsidering the role of imagination, the “Queen of the world”
Xavier Pavie   +2 more
wiley   +1 more source

Aortoplasty and Stent Implantation for the Dacron-Jotec Junction Stenosis: First-in-Human Case Report. [PDF]

open access: yesJACC Case Rep
Garcia-Romero D   +5 more
europepmc   +1 more source

Real‐world outcomes of triplet therapy with gilteritinib, azacitidine and venetoclax in FMS‐like tyrosine kinase 3 (FLT3)‐mutated relapsed/refractory acute myeloid leukaemia: A UK single‐centre experience

open access: yesBritish Journal of Haematology, EarlyView.
In FMS‐like tyrosine kinase 3 (FLT3)‐mutated relapsed/refractory acute myeloid leukaemia, gilteritinib, azacitidine and venetoclax is an effective salvage option with an ORR of 100% (mCRc [MLFS + CRc] 93%). Sixty‐two per cent of patients treated with intention‐to‐transplant proceeded to allogeneic haematopoietic stem cell transplant, of whom 50% remain
Wei Yee Chan   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy